Vertex Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 481.7 USD | 533,67 USD | 362,5 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 554,913 USD | 14 | 4 | 14 | 1 | 1 |
| #Shares | Short [%] | Short Ratio |
| 253.805.417 | 2,22 | 2,45 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Vertex Pharmaceuticals Inc
Mitarbeiter 6.400
Handelsplatz NASDAQ
Ticker Symbol VRTX
IPO Datum 1991-07-24
Adresse 50 Northern Avenue, Boston, MA, United States, 02210
Webseite https://www.vrtx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jeffrey Marc Leiden M.D., Ph.D. | Executive Chairman |
| 2 | Dr. Reshma Kewalramani FASN, M.D. | CEO, President & Director |
| 3 | Mr. Charles F. Wagner Jr. | Executive VP, COO & CFO |
| 4 | Mr. Amit K. Sachdev J.D. | Executive VP & Chief Patient and External Affairs Officer |
| 5 | Dr. Ourania Tatsis Ph.D. | Executive VP and Chief Regulatory & Quality Officer |
| 6 | Dr. Carmen Bozic M.D. | Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer |
| 7 | Ms. Kristen C. Ambrose CPA | Senior VP & Chief Accounting Officer |
| 8 | Dr. Mark Bunnage D.Phil | Executive VP & Chief Scientific Officer |
| 9 | Ms. Susie Lisa C.F.A. | Senior Vice President of Investor Relations |
| 10 | Ms. Joy Liu J.D. | EVP, Chief Legal Officer & Corporate Secretary |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Capital World Investors | 10,00% | 12,26 Mrd. USD |
| 2 | Vanguard Group Inc | 9,50% | 11,65 Mrd. USD |
| 3 | BlackRock Inc | 9,44% | 11,59 Mrd. USD |
| 4 | Capital Research Global Investors | 8,32% | 10,21 Mrd. USD |
| 5 | Vanguard Capital Management, LLC | 6,51% | 7,98 Mrd. USD |
| 6 | State Street Corp | 4,62% | 5,67 Mrd. USD |
| 7 | Amvescap Plc. | 3,11% | 3,82 Mrd. USD |
| 8 | JPMorgan Chase & Co | 2,77% | 3,40 Mrd. USD |
| 9 | Geode Capital Management, LLC | 2,42% | 2,97 Mrd. USD |
| 10 | Vanguard Portfolio Management, LLC | 2,03% | 2,49 Mrd. USD |
| 11 | Capital Research & Mgmt Co - Division 3 | 2,02% | 2,48 Mrd. USD |
| 12 | Loomis, Sayles & Company LP | 1,58% | 1,94 Mrd. USD |
| 13 | AllianceBernstein L.P. | 1,54% | 1,89 Mrd. USD |
| 14 | Wellington Management Company LLP | 1,27% | 1,55 Mrd. USD |
| 15 | Morgan Stanley - Brokerage Accounts | 1,26% | 1,54 Mrd. USD |
| 16 | NORGES BANK | 1,25% | 1,54 Mrd. USD |
| 17 | UBS Asset Mgmt Americas Inc | 1,20% | 1,48 Mrd. USD |
| 18 | Bank of America Corp | 1,13% | 1,39 Mrd. USD |
| 19 | Jennison Associates LLC | 1,08% | 1,32 Mrd. USD |
| 20 | ClearBridge Advisors, LLC | 1,06% | 1,31 Mrd. USD |